These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Intravesical BCG therapy in patients with recurrent superficial bladder tumors]. Sugimoto M; Yamamoto H; Itakura H; Shinohara M; Kinoshita K Gan To Kagaku Ryoho; 1989 Dec; 16(12):3725-8. PubMed ID: 2596855 [TBL] [Abstract][Full Text] [Related]
3. [Lower toxicity with the topical low-dose BCG therapy of superficial bladder carcinoma?]. Mack D; Frick J Urologe A; 1992 Mar; 31(2):88-90. PubMed ID: 1561732 [TBL] [Abstract][Full Text] [Related]
5. [A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer]. Oda H; Seki N; Nabeshima S; Oda T; Nishio S; Yokoyama M; Iwata H; Takeuchi M; Matsumoto A; Terado T Gan To Kagaku Ryoho; 1990 Oct; 17(10):2051-5. PubMed ID: 2221929 [TBL] [Abstract][Full Text] [Related]
6. [Intravesical BCG vaccine in bladder cancer]. Beisland HO; Sander S Tidsskr Nor Laegeforen; 1989 Jun; 109(17-18):1891-2. PubMed ID: 2749672 [TBL] [Abstract][Full Text] [Related]
11. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer. van der Meijden AP Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591 [No Abstract] [Full Text] [Related]
12. BCG vaccine therapy for treatment of superficial bladder cancer. Damianov C; Patrashkov T; Tonchev T; Engibarov A; Kasabov V; Chouchkova M Int Urol Nephrol; 1989; 21(3):305-12. PubMed ID: 2807782 [TBL] [Abstract][Full Text] [Related]